Search Results

Readership/Professor in Receptor Pharmacology and was elected a Fellow of the British Pharmacological Society industry (GSK, Takada, and Firmenich) which have recently been enhanced through him being awarded a Royal Society Industry Fellowship to collaborate with AstraZeneca .

recognized by the attribution of many awards and distinctions including his election as a fellow of the Royal Society of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental

He was elected to the Fellowship of the Royal Society of Edinburgh in 1998 and to the Fellowship of the

recognized by the attribution of many awards and distinctions including his election as a fellow of the Royal Society of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental

Caroline Gorvin is a Wellcome Trust & Royal Society Sir Henry Dale Fellow at the Institute of Metabolism Caroline Gorvin on the web University of Birmingham Endocrine Metabolic GPCRs Society of Endocrinology

of NC-IUPHAR, a member of the Faculty of 1000 and an elected Fellow of the British Pharmacological Society Sexton’s awards include the ASCEPT Lecturer award, Endocrine Society (Australia) Senior Plenary award , Rand Medal (ASCEPT), Paxinos-Watson Award (Australian Neuroscience Society), Vane Medal (BPS), Gordon Hammes Lectureship Award (American Chemical Society) and the GSK Research Excellence award.

Faculty of 1000 (Molecular Pharmacology division) and an elected Fellow of the British Pharmacological Society Sexton’s awards include the Australasian Society for Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Lecturer award, Endocrine Society of Australia Senior Plenary award, Rand Medal (ASCEPT), Paxinos-Watson Award (Australian Neuroscience Society), Vane Medal (BPS), Gordon Hammes Lectureship Award (American Chemical Society) and the GSK Research Excellence award.

mathematical modelling, structural and chemical biology, molecular and cellular pharmacology, medicinal chemistry Abel Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental Therapeutics; the Rand Medal from the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists; the British Pharmacological Society’s Gaddum Memorial Award; the IUPHAR Sir James In 2023, he was elected a Fellow of the Pharmaceutical Society of Australia. " Dr.

mathematical modelling, structural and chemical biology, molecular and cellular pharmacology, medicinal chemistry Abel Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental Therapeutics; the Rand Medal from the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists; the British Pharmacological Society’s Gaddum Memorial Award; the IUPHAR Sir James In 2023, he was elected a Fellow of the Pharmaceutical Society of Australia. " Dr.

mathematical modelling, structural and chemical biology, molecular and cellular pharmacology, medicinal chemistry Abel Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental Therapeutics; the Rand Medal from the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists; the British Pharmacological Society’s Gaddum Memorial Award; the IUPHAR Sir James In 2023, he was elected a Fellow of the Pharmaceutical Society of Australia. " Dr.

Gunnar Schulte is also the scientific secretary of the Swedish Society for Medical Research (SSMF) and Pharmacology, British Journal of Pharmacology, Pharmacological Reviews, and The Journal of Biological Chemistry

2018 and 2021 recipient of the Young Investigator of the Year Awards from the British Pharmacological Society and International Cannabinoid Research Society (ICRS), respectively.

He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics

He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics

He currently serves on the Board of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and is a member of the British Pharmacological Society International Advisory Group

London, respectively, was the youngest person to be elected as a Fellow of the British Pharmacological Society in 2012, and was the recipient of the British Pharmacological Society Novartis Prize in 2017.

Drawing on decades of medicinal chemistry research, the course explores the development of A3 adenosine Jacobson is Chief of the Molecular Recognition Section in the Laboratory of Bioorganic Chemistry at the He earned a B.A. from Reed College and a Ph.D. in Chemistry from the University of California, San Diego Jacobson’s contributions to receptor pharmacology and medicinal chemistry have been recognized with numerous honors including the Medicinal Chemistry Hall of Fame, the Smissman Award, and the Goodman and Gilman

Devane Young Investigator Award from the International Cannabinoid Research Society (ICRS).

He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics

From the early days of ion channel chemistry to pioneering peptide–fluorophore conjugates for the GLP Collaborated across chemistry and biology and felt the translation gap firsthand… …this episode will Broichhagen is a chemical biologist whose work sits at the intersection of organic synthesis, peptide chemistry Born in 1984, he studied chemistry at the University of Erlangen-Nuremberg (2004–2010) and completed His lab integrates synthetic chemistry, theoretical chemistry, cell biology, and imaging to understand

She presented her Ph.D. work at the Society of Endocrinology Conference 2022 and was awarded the best

.” – Alessandro Nicoli He studied pharmaceutical chemistry in Padua, where his fascination with molecular The Moment Chemistry Met Biology Nicoli’s turning point came when he realized that molecules weren’t For Nicoli, chemistry became more than reactions—it became a bridge to biological insight. Nicoli dove into computational chemistry. “We’re living in a golden era for computational chemistry… the tools are out there.

King’s College London, supported by an AJ Clark Ph.D. studentship from the British Pharmacological Society

Together, we discuss how gpcr drug discovery advances when chemists, biologists, and industry partners She earned her PhD in medicinal chemistry from the University of Bari in 2018, including research training Her work centers on GPCR modulators, synthetic chemistry, and enabling robust biological assays through Trained as a chemist, he studied at the University of Erlangen–Nuremberg and completed his PhD at LMU By combining fluorophore design, ligand chemistry, and pharmacology, his work enables precise visualization

. << Back to podcast list Strategic Partner(s) Custom Molecules, Fluorescent Probes: When Chemists Think Pivoting: From Chemistry Company to Discovery Partner Initially focused on tool production, Celtarys “We always start with the problem, then generate the right compound using our chemistry. Together, we’re combining chemistry, biology, and business insight to empower the GPCR research community Her scientific expertise is rooted in organic synthesis and medicinal chemistry, with a particular focus

generation, analysis, and property prediction since 2017" Ben Holland on the web Antiverse The Antibody Society

has also received both Junior (2001) and Senior (2005) investigator awards from the Pharmacological Society

(MFI): a reliable, self-sustaining computational chemistry service provider, developing its own software I am now combining my training as a chemist and as an entrepreneur to grow a sustainable service and

Antonella trained as a medicinal chemist in Italy, followed by a Ph.D. in computational medicinal chemistry

He subsequently returned to Munich as a research associate at the Institute of Pharmaceutical Chemistry Habilitus, he was appointed at the University of Bonn as a Professor of Pharmaceutical Chemistry declining Peter has been chaired Full Professor of Pharmaceutical / Medicinal Chemistry at the Friedrich-Alexander University Erlangen-Nürnberg and declined an offer for the Chair for Pharmaceutical Chemistry at the Peter Gmeiner has been spokesman of the Research Training Group "Medicinal Chemistry of Selective GPCR